Urine qRT-PCR assay as a screening tool for the detection of congenital human cytomegalovirus infection of infants
Abstract
Keywords
Full Text:
PDFReferences
D. G. B. Leonard, Molecular Pathology in Clinical Practice. 2016.
H. Hengel, “Common Characteristics and Distinct Features of Human Pathogenic Herpesviruses,” in Color Atlas of Herpetic Eye Diseases, R. Sundmacher, Ed. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009, pp. 1–4.
V. C. Emery and T. Lazzarotto, “Cytomegalovirus in pregnancy and the neonate,” F1000Research, vol. 6, p. 138, Feb. 2017, doi: 10.12688/f1000research.10276.1.
M. D. Kilby, Y. Ville, and G. Acharya, “Screening for cytomegalovirus infection in pregnancy,” BMJ, p. l6507, Nov. 2019, doi: 10.1136/bmj.l6507.
P. M. Jean Beltran and I. M. Cristea, “The life cycle and pathogenesis of human cytomegalovirus infection: lessons from proteomics,” Expert Rev. Proteomics, vol. 11, no. 6, pp. 697–711, Dec. 2014, doi: 10.1586/14789450.2014.971116.
S. Baron, Ed., Medical microbiology, 4th ed. Galveston, Tex: University of Texas Medical Branch at Galveston, 1996.
M. J. Cannon, T. B. Hyde, and D. S. Schmid, “Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection: Review of CMV shedding in bodily fluids,” Rev. Med. Virol., vol. 21, no. 4, pp. 240–255, Jul. 2011, doi: 10.1002/rmv.695.
S. Manicklal, V. C. Emery, T. Lazzarotto, S. B. Boppana, and R. K. Gupta, “The ‘Silent’ Global Burden of Congenital Cytomegalovirus,” Clin. Microbiol. Rev., vol. 26, no. 1, pp. 86–102, Jan. 2013, doi: 10.1128/CMR.00062-12.
G. Nigro, S. P. Adler, and Congenital Cytomegalic Disease Collaborating Group, “High-dose CMV hyperimmune globulin (HIG) and maternal CMV DNAemia independently predict infant outcome in pregnant women with a primary cytomegalovirus (CMV) infection,” Clin. Infect. Dis., p. ciz1030, Oct. 2019, doi: 10.1093/cid/ciz1030.
T. Tabata et al., “Neutralizing Monoclonal Antibodies Reduce Human Cytomegalovirus Infection and Spread in Developing Placentas,” Vaccines, vol. 7, no. 4, p. 135, Sep. 2019, doi: 10.3390/vaccines7040135.
P. Zelini et al., “Determination of anti-p52 IgM and anti-gB IgG by ELISA as a novel diagnostic tool for detection of early and late phase of primary human cytomegalovirus infections during pregnancy,” J. Clin. Virol., vol. 120, pp. 38–43, Nov. 2019, doi: 10.1016/j.jcv.2019.09.006.
J. B. Taylor and D. J. Triggle, Eds., Comprehensive medicinal chemistry II. Amsterdam: Elsevier, 2007.
DOI: http://dx.doi.org/10.21533/pen.v8i4.1561
Refbacks
- There are currently no refbacks.
Copyright (c) 2020 Emina Huseinbegović, Daria Ler, Mirza Suljagic
This work is licensed under a Creative Commons Attribution 4.0 International License.
ISSN: 2303-4521
Digital Object Identifier DOI: 10.21533/pen
This work is licensed under a Creative Commons Attribution 4.0 International License